Literature DB >> 1680529

6R-tetrahydrobiopterin perfusion enhances dopamine, serotonin, and glutamate outputs in dialysate from rat striatum and frontal cortex.

N Mataga1, K Imamura, Y Watanabe.   

Abstract

The effect of 6R-tetrahydrobiopterin (R-THBP) on neurotransmitter release was investigated using in vivo brain microdialysis in urethane-anesthetized rats. Perfusion of 1.0 mM R-THBP enhanced the level of dopamine output in dialysates collected from the striatum and frontal cortex. R-THBP perfusion also increased serotonin (striatum) and glutamate outputs (striatum and frontal cortex). Dopaminergic terminals in the striatum were destroyed unilaterally by continuous infusion of 6-hydroxydopamine (6-OHDA) using an osmotic minipump system. The effect of R-THBP administration on glutamate level was found to be almost completely suppressed in the 6-OHDA-lesioned side of striatum, while in the intact side of striatum the glutamate level in the dialysates responded normally to R-THBP perfusion. These results suggest that R-THBP may play a role in the mechanisms of release of dopamine, serotonin, and glutamate. The functioning of the catecholaminergic system probably mediates the increase in glutamate output due to R-THBP perfusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680529     DOI: 10.1016/0006-8993(91)90914-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Sulfamethoxazole-trimethoprim double-blind, placebo-controlled, crossover trial in Machado-Joseph disease: sulfamethoxazole-trimethoprim increases cerebrospinal fluid level of biopterin.

Authors:  T Sakai; T Matsuishi; S Yamada; H Komori; H Iwashita
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the Rhesus monkey.

Authors:  Y Tani; T Ishihara; T Kanai; T Ohno; J Andersson; A Lilja; G Antoni; K J Fasth; P Bjurling; G Westerberg
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  The 1.25 A crystal structure of sepiapterin reductase reveals its binding mode to pterins and brain neurotransmitters.

Authors:  G Auerbach; A Herrmann; M Gütlich; M Fischer; U Jacob; A Bacher; R Huber
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

4.  A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein interactions.

Authors:  Lance Swick; Gregory Kapatos
Journal:  J Neurochem       Date:  2006-06       Impact factor: 5.372

Review 5.  Tetrahydrobiopterin biosynthesis, regeneration and functions.

Authors:  B Thöny; G Auerbach; N Blau
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

6.  Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder.

Authors:  Mary Ann Richardson; Laura L Read; Margaret A Reilly; James D Clelland; Catherine L Taylor Clelland
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

7.  Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on in vivo L-[beta-11C]dopa turnover in the rat striatum with infusion of L-tyrosine.

Authors:  H Tsukada; K J Lindner; P Hartvig; Y Tani; P Bjurling; T Kihlberg; G Westerberg; Y Watanabe; B Långström
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Expression, purification, crystallization and preliminary X-ray analysis of sepiapterin reductase from Chlorobium tepidum.

Authors:  Supangat Supangat; Yong Kee Choi; Young Shik Park; Daeyoung Son; Chang-deok Han; Kon Ho Lee
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-01-20

9.  The effect of tetrahydrobiopterin on the in situ phosphorylation of tyrosine hydroxylase in rat striatal synaptosomes.

Authors:  P Ribeiro; S Kaufman
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

10.  Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders.

Authors:  James D Clelland; Laura L Read; Jennifer Smeed; Catherine L Clelland
Journal:  Psychiatry Res       Date:  2018-02-08       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.